X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (90) 90
index medicus (77) 77
hiv (47) 47
hiv infections - drug therapy (42) 42
anti-retroviral agents - pharmacology (41) 41
anti-retroviral agents - therapeutic use (38) 38
antiviral agents (34) 34
animals (31) 31
human immunodeficiency virus--hiv (30) 30
male (26) 26
aids (24) 24
antiretroviral drugs (24) 24
female (24) 24
health aspects (22) 22
highly active antiretroviral therapy (22) 22
pharmacology & pharmacy (21) 21
antiretroviral therapy (20) 20
drug therapy (19) 19
human-immunodeficiency-virus (19) 19
anti-retroviral agents - chemistry (18) 18
hiv-1 (18) 18
virology (18) 18
hiv infection (17) 17
hiv-1 - drug effects (17) 17
infectious diseases (17) 17
therapy (17) 17
anti-retroviral agents - administration & dosage (16) 16
drugs (16) 16
immunology (16) 16
adult (15) 15
research (15) 15
biochemistry & molecular biology (14) 14
infections (14) 14
medicine (14) 14
research article (14) 14
antiretroviral agents (13) 13
acquired immune deficiency syndrome--aids (12) 12
article (12) 12
human immunodeficiency virus (12) 12
acquired immune deficiency syndrome (11) 11
analysis (11) 11
anti-retroviral agents - chemical synthesis (11) 11
biomedicine (11) 11
drug delivery systems (11) 11
microbiology (11) 11
protease inhibitors (11) 11
anti-retroviral agents - adverse effects (10) 10
cells, cultured (10) 10
chemistry, medicinal (10) 10
hiv infections - virology (10) 10
infection (10) 10
mice (10) 10
middle aged (10) 10
virus diseases (10) 10
acquired immunodeficiency syndrome - drug therapy (9) 9
cells (9) 9
drug design (9) 9
immunodeficiency-virus type-1 (9) 9
reverse-transcriptase inhibitors (9) 9
tenofovir (9) 9
virus replication - drug effects (9) 9
viruses (9) 9
zidovudine (9) 9
anti-hiv agents - pharmacology (8) 8
anti-retroviral agents - pharmacokinetics (8) 8
cell biology (8) 8
cell line (8) 8
disease progression (8) 8
drug interactions (8) 8
drug resistance (8) 8
efavirenz (8) 8
hiv infections - complications (8) 8
hiv patients (8) 8
hiv-1 - physiology (8) 8
hiv-infected patients (8) 8
in-vitro (8) 8
inhibition (8) 8
inhibitors (8) 8
multidisciplinary sciences (8) 8
nanoparticles (8) 8
prevention (8) 8
science (8) 8
activation (7) 7
antiretroviral (7) 7
antiretroviral therapy, highly active (7) 7
biochemistry (7) 7
biology (7) 7
cell survival - drug effects (7) 7
drug therapy, combination (7) 7
emtricitabine (7) 7
hiv infections - immunology (7) 7
hiv-1 - genetics (7) 7
mutation (7) 7
pharmacology/toxicology (7) 7
physiological aspects (7) 7
review (7) 7
toxicology (7) 7
active antiretroviral therapy (6) 6
anti-retroviral agents - toxicity (6) 6
disease models, animal (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medicinal Chemistry, ISSN 0022-2623, 07/2007, Volume 50, Issue 15, pp. 3747 - 3750
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 12/2010, Volume 53, Issue 24, pp. 8765 - 8769
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 03/2011, Volume 1222, Issue 1, pp. 83 - 89
Journal Article
Journal Article
Cell Host & Microbe, ISSN 1931-3128, 07/2012, Volume 12, Issue 1, pp. 97 - 108
The human immunodeficiency virus type 1 (HIV) Tat protein, a potent activator of HIV gene expression, is essential for integrated viral genome expression and... 
LOW-LEVEL VIREMIA | ACTIVATION | PROTEIN | ANTIVIRAL THERAPY | HIGH-AFFINITY | MICROBIOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | P-TEFB | VIROLOGY | LONG TERMINAL REPEAT | ACTIVE ANTIRETROVIRAL THERAPY | GENE-EXPRESSION | PARASITOLOGY | Anti-HIV Agents - pharmacology | Transcription, Genetic - drug effects | Gene Expression Regulation, Viral - drug effects | Alkaloids - pharmacokinetics | Humans | Alkaloids - chemical synthesis | Male | Heterocyclic Compounds, 4 or More Rings - pharmacology | Proviruses - drug effects | HIV-1 - physiology | Isoquinolines - pharmacology | Proviruses - genetics | Microsomes, Liver - drug effects | Female | tat Gene Products, Human Immunodeficiency Virus - antagonists & inhibitors | CD4-Positive T-Lymphocytes - virology | Cells, Cultured - virology | Binding Sites | Polycyclic Compounds - chemistry | Promoter Regions, Genetic | Virus Replication - drug effects | Cells, Cultured - drug effects | Alkaloids - pharmacology | HIV-1 - drug effects | tat Gene Products, Human Immunodeficiency Virus - genetics | HIV Infections - virology | Mice, Inbred C57BL | HIV-1 - genetics | Antiretroviral Therapy, Highly Active | Animals | HIV Core Protein p24 - metabolism | HIV Infections - drug therapy | Mice | Alkaloids - chemistry | tat Gene Products, Human Immunodeficiency Virus - metabolism | Virus diseases | Highly active antiretroviral therapy | Antiviral agents | Alkaloids | Messenger RNA | RNA | Genes | Genetic research | HIV (Viruses) | T cells | Gene expression | Anti-HIV agents | HIV-1 | HIV-2 | Tat | HIV persistence | inhibition | Tat activated transcription | anti-retroviral drugs | compound | HAART
Journal Article
Journal Article
Journal of Neuroimmune Pharmacology, ISSN 1557-1890, 3/2007, Volume 2, Issue 1, pp. 120 - 127
Effective antiretroviral therapy (ART) has reduced the incidence of HIV-associated neurocognitive impairment (HNCI) but its prevalence remains high. Clinical... 
serotonin reuptake inhibitors | Neurosciences | Biomedicine | Immunology | HIV | statins | cerebrospinal fluid | Pharmacology/Toxicology | Cell Biology | Virology | Cerebrospinal fluid | Serotonin reuptake inhibitors | Statins | inhibitors | NEUROPSYCHOLOGICAL IMPAIRMENT | COGNITIVE IMPAIRMENT | ANTIRETROVIRAL THERAPY | HIV-1-INFECTED PATIENTS | VALPROIC ACID | HUMAN-IMMUNODEFICIENCY-VIRUS | NEUROSCIENCES | NEUROCOGNITIVE IMPAIRMENT | DOUBLE-BLIND | serotonin reuptake | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | DISEASE PROGRESSION | Central Nervous System - metabolism | Prospective Studies | Hydroxymethylglutaryl-CoA Reductase Inhibitors - chemical synthesis | Anti-Retroviral Agents - chemical synthesis | Humans | Middle Aged | Anti-Retroviral Agents - pharmacology | Acquired Immunodeficiency Syndrome - psychology | Male | Acquired Immunodeficiency Syndrome - cerebrospinal fluid | Acquired Immunodeficiency Syndrome - drug therapy | Serotonin Uptake Inhibitors - chemical synthesis | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Drug Design | Central Nervous System - drug effects | Adult | Female | Serotonin Uptake Inhibitors - pharmacology | Acquired Immunodeficiency Syndrome - virology | Central Nervous System - virology | Cohort Studies | Antiretroviral drugs | FDA approval | Antidepressants
Journal Article